| Identification | Back Directory | [Name]
FR 901537 | [CAS]
161162-21-6 | [Synonyms]
FR 901537
Butanamide, N-[3-[[2-[(2,3-dihydro-6-hydroxy-2-oxo-1H-naphtho[2,1-b][1,4]thiazin-5-yl)thio]ethyl]amino]-3-oxopropyl]-2,4-dihydroxy-3,3-dimethyl-, (2R)- | [Molecular Formula]
C23H29N3O6S2 | [MOL File]
161162-21-6.mol | [Molecular Weight]
507.62 |
| Hazard Information | Back Directory | [Description]
FR 901537 is a new aromatase inhibitor. FR 901537 has antitumor effects. FR901537 is a promising drug in the treatment of estrogen-dependent mammary tumors in postmenopausal women. | [Uses]
FR 901537 is a potent and competitive aromatase inhibitor. FR 901537, a novel naphthol derivative, has the potential for breast cancer research[1]. | [References]
[1] N Oohata, et al. A new aromatase inhibitor, FR901537. I. Taxonomy, fermentation, isolation, physiochemical characteristics and biological activities. J Antibiot (Tokyo). 1995 Aug;48(8):757-62. DOI:10.7164/antibiotics.48.757 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|